A More Severe Non-melanoma Skin Cancer Phenotype Is Seen in Patients with Inflammatory Bowel Disease on Tumor Necrosis Factor-α Antagonists

被引：0

作者：

Cassandra M. Townsend

Reena Khanna

Aze Suzanne Wilson

机构：

[1] Western University,Division of Gastroenterology, Department of Medicine

[2] Western University,Division of Clinical Pharmacology, Department of Medicine

[3] Western University,Department of Physiology and Pharmacology

来源：

Digestive Diseases and Sciences | 2021年 / 66卷

关键词：

Ulcerative colitis; Crohn’s disease; Inflammatory bowel disease; Tumor necrosis factor-; antagonists; Non-melanoma skin cancer;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：4436 / 4440

页数：4

共 50 条

[1] A More Severe Non-melanoma Skin Cancer Phenotype Is Seen in Patients with Inflammatory Bowel Disease on Tumor Necrosis Factor-α Antagonists
Townsend, Cassandra M.
Khanna, Reena
Wilson, Aze Suzanne
DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (12) : 4436 - 4440
[2] Increased Risk for Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel Disease
Long, Millie D.
Herfarth, Hans H.
Pipkin, Clare A.
Porter, Carol Q.
Sandler, Robert S.
Kappelman, Michael D.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (03) : 268 - 274
[3] Melanoma and non-Melanoma Skin Cancer in Inflammatory Bowel Disease Patients following Tumor Necrosis Factor-α Inhibitor Monotherapy and in Combination with Thiopurines: Analysis of the Food and Drug Administration Adverse Event Reporting System
McKenna, Michael R.
Stobaugh, Derrick J.
Deepak, Parakkal
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2014, 23 (03) : 267 - 271
[4] SCREENING FOR MELANOMA AND NON-MELANOMA SKIN CANCER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AT A TERTIARY CARE HOSPITAL
Tageldin, Omar
Zelman, Sara
Parsa, Nour A.
Mansoor, Muhammad S.
Batool, Asra
GASTROENTEROLOGY, 2020, 158 (06) : S422 - S422
[5] No Increased Risk of Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel Disease Using Thiopurines
van Schaik, Fiona D.
Smeets, Hugo M.
van der Heijden, Geert J.
Siersema, Peter D.
van Oijen, Martijn G.
Oldenburg, Bas
GASTROENTEROLOGY, 2011, 140 (05) : S770 - S771
[6] Risk of non-melanoma skin cancer with thiopurine use in inflammatory bowel disease
Subramaniam, Kavitha
Pavli, Paul
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (02) : 193 - 194
[7] Drug Insight: antagonists of tumor-necrosis factor-α in the treatment of inflammatory bowel disease
John T Chang
Gary R Lichtenstein
Nature Clinical Practice Gastroenterology & Hepatology, 2006, 3 : 220 - 228
[8] Drug insight:: Antagonists of tumor-necrosis factor-α in the treatment of inflammatory bowel disease
Chang, JT
Lichtenstein, GR
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2006, 3 (04): : 220 - 228
[9] Recurrence of Non-melanoma Skin Cancer in Inflammatory Bowel Disease Patients Who Continue Thiopurines After Developing Incident Non-melanoma Skin Cancer While on a Thiopurine
Shah, Yash
Trivedi, Chinmay
Khan, Nabeel
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S327 - S327
[10] Understanding the impact of TNF-α antagonists on the severity of non-melanoma skin cancer in inflammatory bowel disease and the consequences for therapy
Townsend, C.
Khanna, R.
Wilson, A. S.
JOURNAL OF CROHNS & COLITIS, 2020, 14 : S370 - S371

← 1 2 3 4 5 →